Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study to Determine How Prior Therapy With Alendronate or Risedronate in Postmenopausal Women With Osteoporosis Influences the Clinical Effectiveness of Teriparatide

NCT00130403 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00130403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00130403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study to Determine How Prior Therapy With Alendronate or Risedronate in Postmenopausal Women With Osteoporosis Influences the Clinical Effectiveness of Teriparatide
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2004
Completion date
March 31, 2007
Enrollment
290 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, postmenopausal